Nan Fung Life Sciences formed part of a consortium of new and existing backers that injected $71m into hearing aid manufacturer Eargo.
US-based hearing aid provider Eargo completed a $71m funding round yesterday backed by Nan Fung Life Sciences, a subsidiary of property development group Nan Fung.
Gilde Healthcare and Longitude Capital co-led the round, which also attracted New Enterprise Associates (NEA) and the Charles and Helen Schwab Foundation.
Eargo markets rechargeable hearing ais that fit entirely within the ear canal, making them essentially invisible and helping wearers overcome the stigma often associated with such devices. The company also provides an online…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
